These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22797722)

  • 1. Valproate-induced panhypogammaglobulinemia.
    Eom TH; Lee HS; Jang PS; Kim YH
    Neurol Sci; 2013 Jun; 34(6):1003-4. PubMed ID: 22797722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproate-induced pancytopenia in a patient with infantile spasms].
    Taniguchi Y; Hattori H; Higuchi Y; Maihara T; Jung EY; Furusho K
    No To Hattatsu; 1997 Jan; 29(1):73-5. PubMed ID: 8986101
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial.
    Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR
    Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous valproate associated with significant hypotension in the treatment of status epilepticus.
    White JR; Santos CS
    J Child Neurol; 1999 Dec; 14(12):822-3. PubMed ID: 10614572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of pancytopenia.
    Keown P; McAllister-Williams H; Young A
    J Psychopharmacol; 2006 Sep; 20(5):690-2. PubMed ID: 16714327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine-induced hypogammaglobulinemia.
    Ozaras N; Goksugur N; Eroglu S; Tabak O; Canbakan B; Ozaras R
    Seizure; 2012 Apr; 21(3):229-31. PubMed ID: 22251925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial.
    Mehta V; Singhi P; Singhi S
    J Child Neurol; 2007 Oct; 22(10):1191-7. PubMed ID: 17940245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy and IgA deficiency--the effect of sodium valproate.
    Joubert PH; Aucamp AK; Potgieter GM; Verster F
    S Afr Med J; 1977 Oct; 52(16):642-4. PubMed ID: 337537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R; Güzel O; Ceylan G; Yılmaz Ü; Ağın H
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum drug level-related sodium valproate-induced hair loss.
    Ramakrishnappa SK; Belhekar MN
    Indian J Pharmacol; 2013; 45(2):187-8. PubMed ID: 23716898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
    Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intravenous valproate in convulsive status epilepticus in the future.
    Kwan SY
    Acta Neurol Taiwan; 2010 Jun; 19(2):78-81. PubMed ID: 20830628
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of delirium and subsequent pancytopenia associated with the oral loading of valproic acid.
    Chae BJ; Kang BJ
    J Clin Psychiatry; 2005 Jun; 66(6):801-2. PubMed ID: 15960580
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
    Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
    An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disabling Resting Tremors Induced by the Short-term Infusion of Valproate: A Reversible Phenomenon.
    Gupta A; Kushwaha S
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():615. PubMed ID: 30619645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of valproate across the ages. Treatment of epilepsy in children.
    Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A
    Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in verbal memory after withdrawal of carbamazepine and valproate in patients with well-controlled epilepsy: a randomized, double-blind study.
    Hessen E; Lossius MI; Gjerstad L
    Acta Neurol Scand; 2011 Jun; 123(6):385-9. PubMed ID: 20955400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible panhypogammaglobulinemia associated with phenytoin treatment.
    Pereira LF; Sanchez JF
    Scand J Infect Dis; 2002; 34(10):785-7. PubMed ID: 12477340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.